Key facts
- An abstract on biomarker testing for lung cancer was released.
- The abstract highlights progress and gaps in biomarker testing.
- Dr. Rami Owera, a medical oncologist with Florida Cancer Specialists & Research Institute, is a co-author.
An abstract co-authored by Dr. Rami Owera, a medical oncologist and hematologist with Woodlands Specialty Physicians, a division of Florida Cancer Specialists & Research Institute, details findings from the MYLUNG study. The abstract focuses on biomarker testing for lung cancer, highlighting both the progress made and the existing gaps in current testing methodologies. The research aims to provide insights into molecularly informed approaches for treating lung cancer.